12/4
01:01 pm
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/4
07:00 am
podd
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
Low
Report
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
12/2
04:52 pm
podd
Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]
Low
Report
Insulet: Excellent Business, Valuation Hurdle Remains [Seeking Alpha]
11/26
08:01 am
podd
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]
Low
Report
Artisan International Small-Mid Fund Q3 2025 Contrarianism Pays Off [Seeking Alpha]
11/24
06:21 pm
podd
How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]
Low
Report
How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets [Yahoo! Finance]
11/24
08:05 am
podd
Insulet (NASDAQ:PODD) was given a new $432.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Insulet (NASDAQ:PODD) was given a new $432.00 price target on by analysts at Canaccord Genuity Group Inc..
11/24
07:19 am
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/21
12:06 pm
podd
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
11/21
11:00 am
podd
Insulet (NASDAQ:PODD) was given a new $412.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Insulet (NASDAQ:PODD) was given a new $412.00 price target on by analysts at Truist Financial Corporation.
11/21
09:26 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Leerink Partners from $385.00 to $386.00. They now have an "outperform" rating on the stock.
Medium
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Leerink Partners from $385.00 to $386.00. They now have an "outperform" rating on the stock.
11/21
09:26 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Raymond James Financial, Inc. from $366.00 to $385.00. They now have an "outperform" rating on the stock.
Medium
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Raymond James Financial, Inc. from $366.00 to $385.00. They now have an "outperform" rating on the stock.
11/21
09:05 am
podd
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/21
08:05 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at BTIG Research from $370.00 to $380.00. They now have a "buy" rating on the stock.
High
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at BTIG Research from $370.00 to $380.00. They now have a "buy" rating on the stock.
11/20
08:17 pm
podd
Insulet Corporation (PODD) Analyst/Investor Day Transcript [Seeking Alpha]
Medium
Report
Insulet Corporation (PODD) Analyst/Investor Day Transcript [Seeking Alpha]
11/20
12:30 pm
podd
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
Medium
Report
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
11/19
07:00 am
podd
Insulet (NASDAQ:PODD) was given a new $400.00 price target on by analysts at UBS Group AG.
Low
Report
Insulet (NASDAQ:PODD) was given a new $400.00 price target on by analysts at UBS Group AG.
11/13
08:11 am
podd
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $370.00 price target on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $370.00 price target on the stock.
11/13
06:02 am
podd
There May Be Some Bright Spots In Insulet's (NASDAQ:PODD) Earnings [Yahoo! Finance]
Low
Report
There May Be Some Bright Spots In Insulet's (NASDAQ:PODD) Earnings [Yahoo! Finance]
11/9
09:31 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $375.00 to $388.00. They now have a "buy" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $375.00 to $388.00. They now have a "buy" rating on the stock.
11/8
07:05 pm
podd
Insulet (PODD): Evaluating Valuation After Q3 2025 Results, Upgraded Guidance, and Omnipod Expansion [Yahoo! Finance]
Low
Report
Insulet (PODD): Evaluating Valuation After Q3 2025 Results, Upgraded Guidance, and Omnipod Expansion [Yahoo! Finance]
11/8
09:31 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Sanford C. Bernstein from $400.00 to $410.00.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Sanford C. Bernstein from $400.00 to $410.00.
11/7
05:36 pm
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $399.00 to $428.00. They now have a "buy" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $399.00 to $428.00. They now have a "buy" rating on the stock.
11/7
02:22 pm
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Royal Bank Of Canada from $365.00 to $370.00. They now have an "outperform" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Royal Bank Of Canada from $365.00 to $370.00. They now have an "outperform" rating on the stock.
11/7
12:57 pm
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at UBS Group AG from $320.00 to $355.00. They now have a "neutral" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at UBS Group AG from $320.00 to $355.00. They now have a "neutral" rating on the stock.
11/7
09:38 am
podd
Insulet (NASDAQ:PODD) had its price target raised by analysts at Wells Fargo & Company from $350.00 to $360.00. They now have an "overweight" rating on the stock.
Low
Report
Insulet (NASDAQ:PODD) had its price target raised by analysts at Wells Fargo & Company from $350.00 to $360.00. They now have an "overweight" rating on the stock.